The Petrie-Flom Center at Harvard Law School is in an exciting phase of expansion. One of our new initiatives is this blog, which we hope you’ll visit regularly for insightful commentary on current issues in health law policy, biotechnology, and bioethics. Petrie-Flom affiliates will be blogging their thoughts here, as will a number of other leading experts from Harvard and beyond – introductions (and lots of them!) can be found below, or on the About Us page. We’ll also be posting news and announcements from around the world, from upcoming conferences and calls for papers to job openings and funding opportunities.
Our aim is for this site to become your go-to place for all things related to health policy, biotech, and bioethics – from the legal perspective. If there’s something you’d like to see here (or something you’d like to see done differently), please let us know. We’re new at this whole blogging thing, so we’ve got a lot to learn. But we hope you’ll bear with us as we bring together a bunch of great people for some really great (virtual) conversation. On that note, please join in the conversation yourself – and comment, comment, comment!
Glenn is one of the world’s leading experts on the intersection of bioethics and the law, as well as health law. From Seoul to Krakow to Vancouver, he has spoken at legal, medical, and industry conferences around the world, and his work has been covered on PBS, NPR, ABC, Mother Jones, the New York Times, the BostonGlobe, and several other media venues.
Glenn’s current projects relate to reproduction/reproductive technology and to medical tourism – the travel of patients who are residents of one country, the “home country,” to another country, the “destination country,” for medical treatment. His past work has included projects on end of life decision-making, FDA regulation, research ethics, and commodification. His award-winning academic work has appeared in the journals such as the New England Journal of Medicine, the Stanford, Southern California, Georgetown Cornell, Minnesota, Iowa, and Hastings Law Reviews, the Harvard Journal of Law and Negotiation, the Harvard Journal of Law and Technology, the Food and Drug Law Journal, the Journal of Law, Medicine, and Ethics, the American Journal of Public Health, and the Hastings Center Report. He is the editor of “The Globalization of Healthcare: Legal and Ethical Challenges” (Oxford University Press, Forthcoming 2012), and is currently working on writing a new book “Patients with Passports: Medical Tourism, Ethics, and Law”.
Prior to joining the HLS faculty, Glenn served as a clerk to Chief Judge Michael Boudin, U.S. Court of Appeals for the First Circuit. He also served as an appellate attorney for the U.S. Department of Justice, Civil Division, Appellate staff, where he acted as lead counsel in over 12 Circuit Court cases and represented the United States in the U.S. Supreme Court, in conjunction with the Solicitor General’s office. Immediately before joining the faculty he was a fellow at the Petrie-Flom Center.
Holly is the Executive Director of the Petrie-Flom Center, where she was previously an academic fellow. Her scholarly work focuses on the ethics of human subjects research and issues at the heart of the doctor-patient relationship, such as conflicts of conscience in health care. Holly practiced pharmaceuticals law at Hogan & Hartson, LLP in Washington, DC (now Hogan Lovells), and worked as a bioethicist in the Human Subjects Protection Branch at NIH’s Division of AIDS. She also served as Senior Policy and Research Analyst for President Obama’s Commission for the Study of Bioethical Issues. Holly graduated from the University of Pennsylvania Law School, and earned her Master of Bioethics from the University of Pennsylvania School of Medicine. She is currently an IRB member at The Fenway Institute in Boston.
Although our bloggers come from all over the place, Bill of Health is housed within the Petrie-Flom Center at Harvard Law School. So here’s a little but about us, in case you’re interested.
The Center is entering its 8th year, and has produced some fantastic scholars (and scholarship) to date in the fields of health law policy, biotechnology, and bioethics. Our main programs have been fellowships for post-docs and students, as well as a variety of workshops, panel discussions, and conferences. But we’re expanding now, into the blogging world and elsewhere. If you’d like to learn more, check out our website and add yourself to our list serve for periodic updates. And if you’re ever in Cambridge, please stop by to say hi!
Bill of Health is lucky to have lined up a few really great institutional collaborators. Let’s meet them:
First, HealthLawProf Blog will be cross-posting its material on our site, helping Bill of Health achieve its goal of becoming a true one-stop-shop for news and commentary in health law, biotech, and bioethics.
And last but not least, Yale’s Interdisciplinary Center for Bioethics, which puts together a stellar weekly round-up of recently published bioethics scholarship, op-eds, news items, etc. will be allowing us to post a version of that round-up here. Check for it on Friday afternoons.
If you’re interested in pursuing an institutional collaboration, please let us know. Contact Holly Fernandez Lynch, hlynch at law dot harvard dot edu.
We’re excited to introduce and welcome Art Caplan to our blogging community. He will be cross-posting some of his commentary written for other media outlets here, and providing original content to Bill of Health on occasion. Follow him on Twitter @ArthurCaplan.